The global defibrillators market is anticipated to grow at a significant CAGR of 6.9% during the forecast period. One of the primary drivers for the market is a growing awareness of cardiovascular events in developing markets. The number and use of defibrillators in the UAE are noticeably low. However, in the coming years, the presence of local distributors and increased activities to create awareness about cardiac health are projected to contribute to market growth.

The global database encryption market is anticipated to grow at a significant CAGR of 30.1% during the forecast period. Personal data lockers are currently being utilized to secure an organization's personal and financial information for data security. The increasing requirement for enterprises to comply with regulatory norms, the expanding need for cloud-based databases, and the availability of adaptable encryption software have all contributed to the adoption of database encryption. Cloud adoption is bringing with it its own set of issues, such as data privacy and security. 

The global cyber security market is anticipated to grow at a CAGR of 11.1% during the forecast period. The major factor driving the growth of the global cyber security market during the forecast period is the increasing cases of security breaches due to cloud misconfigurations and the increasing adoption of cloud-based solutions across the globe. According to CheckPoint report 2020, there was a threat of 68% configuration error in the cloud platform which was followed by 58% of unauthorized cloud access and 52% unsecured interfaces as well as 50% account theft. Furthermore, as per the NETSCOUT Threat Intelligence report, in 2020, DDoS attacks became more prevalent with 4.83 million attacks in the first half of the year.

The global critical care equipment market is anticipated to grow at a considerable CAGR of 9.4% during the forecast period. The factor contributing to the growth of the critical care equipment market is a rise in the prevalence of COVID-19 patients and the number of diabetic patients and smokers. Moreover, due to COVID-19, there is an increase in the number of viral infections and bacteria which is the main cause of heart disease. In addition, companies are strategically increasing their product portfolios and production facility to meet the demand during the pandemic and to grow in the market through acquisition and partnership. 

The global conditional access systems (CAS) market is anticipated to grow at a considerable CAGR of 8% during the forecast period. CAS market offers significant expansion opportunities with the development of cloud-based CAS for multiple devices. Cloud-based CAS includes content security management, which is offered remotely through a hosted conditional access solution. This reduces the upgrade and other operational costs related to CAS. Cloud-based CAS is designed to provide high-level content security for any type of content and on any type of network. 

The global cloud infrastructure services market is anticipated to grow at a considerable CAGR of 10.7% during the forecast period. Owing to its cost-effectiveness and accessibility, the public cloud-based deployment strategy is gaining popularity. The public cloud is built on the cloud computing concept, which distributes computer resources (such as CPUs, servers, and racks) across multiple enterprises based on demand.

The global antimicrobial textile market is anticipated to grow at a CAGR during the forecast period (2022-2028). The market growth is driven by the presence of prominent players that are focuses on adopting numerous strategies, such as product launch, business expansion, mergers and acquisition, partnership, collaboration, joint venture, and agreement to stay competitive in the antimicrobial textiles market. For instance, in June 2020, Birla Cellulose, the pulp and fibre business of Aditya Birla group had launched a new innovative fibre “Liva” which imparts antimicrobial properties to textiles.

The global hypereosinophilic syndrome drug market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). All the major players in the global hypereosinophilic syndrome drug market are involved in strategic alliances like acquisitions, partnerships, and collaborations to launch new drugs, to stay competitive in the market. Moreover, the rising US FDA approvals to the drugs developed by major pharmaceutical companies targeting hypereosinophilic syndrome also the factor that is creating significant scope for the market growth.

The global glycosylated hemoglobin and c peptide market is anticipated to grow at a considerable CAGR during the forecast period. Pharmaceutical companies are working on developing effective drugs which are helpful in the treatment of chronic disorders such as diabetes. No of patients with chronic ailments are increasing in all regions of the world. As per the WHO, 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes.

The global inclusion body myositis (IBM) market is expected to grow at a significant CAGR during the forecast period. Muscle weakness and damage are caused by inclusion body myositis, a rare condition. IBM symptoms include progressive weakness in the muscles of the hand, forearm, thigh, and lower leg, but these symptoms vary and are not unique to this condition. The increasing prevalence of IBM around the world is a major factor driving demand for the global Inclusion body myositis market. IBM affects males slightly more often than females. Its prevalence is estimated to be between 10-112 people per 1,000,000 in the general population.